Imprecision lets down Opus
This article was originally published in Clinica
Behring's Opus Magnum immunoassay system is user friendly but imprecision is disappointing, says a UK Medical Devices Agency evaluation report. The MDA team liked the design and found both the software and instrument itself easy to use.
You may also be interested in...
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.
Lilly has launched a similar antibody product, but demand is expected to outpace supply for the foreseeable future.